Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Calgenex’ Dermalleve

This article was originally published in The Tan Sheet

Executive Summary

Tampa, Fla.-based Calgenex announces the launch of Dermalleve, an over-the-counter topical treatment for psoriasis, eczema and seborrheic dermatitis that combines 1% hydrocortisone with natural ingredients to moisturize and nourish skin, the firm states Sept. 27. The product contains natural ingredients such as alpha-hydroxy acids, skin-nourishing nutrients and skin conditioners such as aloe vera, shea butter, vitamin E, jojoba oil and silicone. The product "helps to gently remove dead skin cells while skin-nourishing nutrients, conditioners and moisturizers support healthy skin," Calgenex says. Demalleve also applies easily and evenly because it has the consistency of a lubricant unlike other anti-itch creams which can be too thick, the company asserts. The product is available on Calgenex's website for $19.95 and the firm is supporting the launch with radio ads and TV infomercials...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS099794

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel